HealthIndia’s First Dengue Vaccine: A New Shield Against a Growing Monsoon Threat
India’s approval of Qdenga marks a major new chapter in dengue prevention, but doctors and public-health experts stress that vaccination cannot replace mosquito control, early diagnosis and timely medical care.After decades of relying largely on mosquito control and supportive treatment, India has approved its first dengue vaccine. Qdenga, developed by Takeda, is authorised for people aged 4 to 60 and targets all four dengue virus serotypes. But the vaccine is not a complete solution: experts continue to emphasise eliminating stagnant water, preventing mosquito bites and recognising warning signs of severe dengue early.
By Aalimi Nation · 5 min read